Assessment of Contraceptive Counseling and Contraceptive Use in Women After Bariatric Surgery by Damhof, Michiel A et al.
  
 University of Groningen
Assessment of Contraceptive Counseling and Contraceptive Use in Women After Bariatric
Surgery






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Damhof, M. A., Pierik, E., Krens, L. L., Vermeer, M., van Det, M. J., & van Roon, E. N. (2019). Assessment
of Contraceptive Counseling and Contraceptive Use in Women After Bariatric Surgery. Obesity Surgery,
29(12), 4029–4035. https://doi.org/10.1007/s11695-019-04084-z
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 19-05-2020
ORIGINAL CONTRIBUTIONS
Assessment of Contraceptive Counseling and Contraceptive Use
in Women After Bariatric Surgery
Michiel A. Damhof1 & Esther Pierik2 & Lisanne L. Krens3 & Marloes Vermeer4 & Marc J. van Det5 & Eric N. van Roon2,6
# The Author(s) 2019
Abstract
Background Reproductive-aged women are, according to American and European guidelines, recommended to avoid pregnancy
for 12–24 months after bariatric surgery. Oral contraceptives may have suboptimal efficacy after malabsorptive bariatric
procedures.
Aim The aim of this study was to assess contraceptive use pre- and postoperatively in women who underwent bariatric surgery in
two obesity clinics in The Netherlands. Also, the recall of contraceptive and pregnancy counseling was investigated.
Methods A validated questionnaire was performed among women aged 18–45 years who underwent bariatric surgery from
October 2017 through August 2018.
Results In total, 230 women were eligible for final analysis. Postoperatively, 60% used safe contraception, 16.1% unsafe
contraception, and 23.9% no contraception. In this study, 43.7% of women using a potential unsafe contraceptive method
preoperatively switched to a safe method of contraception postoperatively (p < 0.0001). Only 62.6% of women confirmed to
have received contraceptive counseling, mainly preoperatively. The odds ratio for receiving contraceptive counseling and using
safe contraceptive methods compared with not receiving contraceptive counseling was 2.20 (95% CI, 1.27–3.79; p = 0.005).
Eighty-three percent confirmed that they have received counseling regarding delaying a pregnancy, and 52.6%were familiar with
the recommendation to avoid a pregnancy for 24 months postoperatively.
Conclusions In our study, 60% ofwomen are using safe contraception postoperatively. Contraceptive counseling is suboptimal as
62.6% recall receiving counseling. Those who confirmed receiving counseling were more likely to use safe contraception after
bariatric surgery. More counseling and monitoring in the postoperative and in the outpatient setting is recommended.
Keywords Bariatric surgery . Gastric bypass . Contraception . Counseling . Pregnancy
Introduction
Bariatric surgery is a safe and effective treatment for morbid
obesity. Approximately 50% of women undergoing bariatric
surgery are of reproductive age [1–3]. The American College
of Obstetricians and Gynecologists (ACOG) and the
American Society of Metabolic and Bariatric Surgery
(ASMBS) [4] recommend preventing pregnancy during the
first 12–24 months following bariatric surgery [5–7]. The in-
terval of 12–24 months is important since the initial months
following surgery are associated with rapid weight loss, which
could potentially cause adverse effects to a pregnancy, such as
intrauterine growth restriction, anemia, and neural tube de-
fects due to maternal nutritional status. Pregnancies occurring
sooner than 24 months after bariatric surgery were associated
with a higher incidence of preterm deliveries [6]. Furthermore,
several international cohort studies reported an increased risk
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for significant maternal anemia and an increase in small-for-
gestational-age babies for women with prior bariatric surgery
when compared with BMI-matched controls. In these studies,
there was no difference in the incidence of congenital
malformations between the two groups. On the other hand,
these studies also showed a decreased risk for maternal gesta-
tional diabetes mellitus, a decreased incidence of preeclamp-
sia, and a decreased incidence of emergent cesarean delivery
for women after bariatric surgery compared with BMI-
matched controls [8–11].
The altered reproductive hormone profile associated with
morbid obesity seems to reverse, either partially or totally,
after bariatric surgery. This may result in restoration of the
normal ovulation and enhanced fertility. The risk of an un-
planned pregnancy may therefore be increased after bariatric
surgery, and the use of adequate contraception for womenwho
undergo bariatric surgery is important [12].
The European Society of Contraception (ESC) and Centers
for Disease Control (CDC) medical eligibility criteria for con-
traceptive discourage the use of combined oral contraceptives
(COCs) or progesterone-only pills (POPs) in postbariatric pa-
tients, due to possible decreased efficacy secondary to
malabsorptive procedures [13, 14]; however, adequate evi-
dence is limited to a few pharmacokinetic studies.
Andersen et al. found no significant differences in basal
levels of estradiol, estrone, testosterone, and progesterone
compared with non-operated obese patients [15]. Victor
et al. demonstrated significantly lower plasma levels of both
norethisterone and levonorgestrel, suggesting a reduced ab-
sorptive capacity and risk for contraceptive failure [16].
Both studies, however, were performed in women who had
undergone jejunoileal bypass, a procedure that is no longer
performed.
Recently, Ginstman et al. reported no clinically sig-
nificant changes in etonogestrel pharmacokinetics after
Roux-en-Y gastric bypass (RYGB), suggesting that oral
desogestrel (which is converted to the active metabolite
etonogestrel) may be used by women after the proce-
dure; however, the sample size was limited and the lack
of sample size calculation limits the ability to draw
conclusions. These results need confirmation in larger
studies [17].
Mengesha et al. reported in a cross-sectional study that
66% of 363 reproductive-aged women in the USA after bar-
iatric surgery, recruited through Facebook, used a contracep-
tion method postoperatively, of which 27% were oral contra-
ceptives [18]. In Sweden, Ginstman et al. reported, using a
questionnaire study, that in 563 women aged 18–45 years
who underwent bariatric surgery, 70.1% used any contracep-
tive method, of which 15.5% were oral contraceptives, and
3% reported becoming pregnant postoperatively in spite of
using contraception. Also, 24.8% actively stated that they
did not receive any contraceptive advice postoperatively [19].
In Belgium, Luyssen et al. found that in 71 women of
reproductive age who underwent bariatric surgery, the usage
of short-acting hormonal contraceptives decreased from
39.4% preoperatively to respectively 27.1% and 14.9% at 6
and 12 months postoperatively. Menstrual cycle and sexual
behavior did not differ before and after surgery [20].
As there is little information known and the possible risk of
an unplanned pregnancy after bariatric surgery, the aim of this
study was to prospectively assess contraceptive use pre- and
postoperatively in women who underwent bariatric surgery in
two obesity clinics in The Netherlands. Also, we investigated
the recall of contraceptive and pregnancy counseling given
during the bariatric care program in these clinics.
Methods
Study Population
From October 2017 until August 2018, a web-based question-
naire was sent to all women aged 18–45 years who underwent
a bariatric procedure within the last 5 months, in the obesity
clinics of Ziekenhuisgroep Twente (ZGT) and Medical Center
Leeuwarden (MCL), in The Netherlands. A pregnancy delay
of 24months postoperatively is recommended in these obesity
clinics. In the bariatric care program of both clinics, contra-
ceptive and pregnancy counseling is given preoperatively ver-
bally during the information meeting and also in writing in the
information brochure. Further counseling may be given by
different healthcare providers at any point in the bariatric care
program; however, this is not standardized.
Women were identified and enrolled by their bariatric
healthcare provider during an information meeting in the bar-
iatric care program who explained the objective of this study
and asked for a written informed consent.
Women received the questionnaire using a hyperlink by
email and were deidentified in the survey database
(SurveyMonkey®). Those who had not completed the ques-
tionnaire within 2 weeks were sent a reminder. Only complet-
ed questionnaires were eligible for analysis.
Questionnaire
The survey focused on contraceptive and pregnancy counsel-
ing and contraceptive use pre- and postoperatively in women
of reproductive age (18–45 years). This survey was pretested
at the outpatient clinic in a focus group. Ten women, who
already underwent bariatric surgery, were asked to answer
the questions in the questionnaire face to face with one of
the researchers, and all comments were noted and used to
modify the questionnaire accordingly.
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Objectives
The primary objective of this study was to assess safe contra-
ceptive use pre- and postoperatively in women who
underwent bariatric surgery, defined as the percentage of
womenwho use safe and effective contraception after bariatric
surgery according to international guidelines. The use of
COCs and POPs was considered unsafe. Long-acting contra-
ceptives (injections, implants, IUDs, and pessaries) were con-
sidered safe methods of contraception.
Secondary objectives were to assess the percentage of wom-
en who switched from an unsafe contraceptive method to a safe
contraceptive method after bariatric surgery and to assess the
recall of contraceptive and pregnancy counseling and received
information in the bariatric care program. Also, the possible
relation between receiving contraceptive counseling and the
safe use of contraception postoperatively is investigated.
Statistical Analysis
SPSS version 25.0 was used to analyze the collected data,
using descriptive statistics. Logistic regression was used to
analyze the possible relation between use of safe contracep-
tion postoperatively and the recall of contraceptive counsel-
ing. We determined covariates in the multivariate regression
model that we considered potential confounders in the rela-
tionship between counseling and postoperative contraceptive
use (i.e., age, civil status, education level, obesity clinic, or
surgical procedure). A post hoc McNemar-Bowker test was
performed to analyze the degree of switching of contraception
postoperatively. The level of significance was set at p < 0.05.
Results
Study Population
For this study, 315 women provided a written informed con-
sent and received a questionnaire; 249 women (79.1%)
responded. In total, the results of 230 women were eligible
for final analysis. The collected data of 19 women were ex-
cluded as they did not meet the inclusion criteria (N = 5) or the
questionnaire was not filled out completely (N = 3). Also,
women with a history of surgery for removal of the uterus,
ovaries, or oviducts (N = 11) were excluded from the analysis
as contraceptive use is not relevant for this group. Table 1
shows the baseline characteristics of the study population.
Contraceptive Method Pre- and Postoperatively
The contraceptive methods used pre- and postoperatively are
shown in Fig. 1. Postoperatively, 60% of women used a safe
method of contraception. In this study, 43.7% of users with
unsafe contraception preoperatively switched to a safe method
of contraception postoperatively (p < 0.0001). The use of
short-acting unsafe contraceptives COCs and POPs decreased
from 30.8% preoperatively to 16.1% postoperatively
(p < 0.0001). Usage of long-acting safe contraceptives in-
creased from 44.7 to 60.0% (p < 0.0001).
Table 1 Demographic characteristics of study population (n = 230)
Characteristics
Age in years, median (IQR) 35.5 (11.0)
Preoperative weight in kg, mean (SD) 127.7 (17.9)
Present weight in kg, mean (SD) 107.3 (17.9)
Preoperative BMI in kg/m2, mean (SD) 43.9 (5.5)
Present BMI in kg/m2, mean (SD) 36.9 (5.7)
Civil status
No current relationship 49 (21.3%)
Relationship 181 (78.7%)
Education level
Low (primary school) 9 (3.9%)
Middle (high school) 169 (73.5%)










Sleeve gastrectomy 15 (6.5%)
Time since surgery in months, median (IQR) 1.91 (2.26)
BMI body mass index, RYGB Roux-en-Y gastric bypass, OAGB one-
anastomosis gastric bypass, MCL Medisch Centrum Leeuwarden, ZGT
Ziekenhuisgroep Twente
bOf women using no contraception postoperatively 89% responded to have a partner. 
Fig. 1 Contraceptive methods used pre- and postoperatively (N = 230).
bOf women using no contraception postoperatively, 89% responded to
have a partner
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Approximately 24% of women in this study population
were not using any method of contraception postoperatively.
In this group of women, 89% reported to be involved in a
relationship. Also, four women using unsafe contraception
preoperatively switched to using no contraception postopera-
tively. An overview of contraceptive use classified by safe,
unsafe, or no use of contraception pre- and postoperatively
respectively is given in Table 2.
Contraceptive and Pregnancy Counseling
About 63% of women confirmed to have received any
counseling about contraception, and 83% about delaying
pregnancy in the bariatric care program. Approximately 71%
of women reported to have received information in writing
regarding contraception, and 72% regarding pregnancy in
the information meeting preoperatively. In Table 3, we have
summarized these results from the questionnaire by healthcare
provider and information source.
In this questionnaire, women were asked if they have re-
ceived counseling about a delay of pregnancy postoperatively
and which minimal period of time was advised for this delay.
Approximately 53% of women indicated the recommended
delay of 24 months postoperatively as is shown in Table 4.
None of the women was pregnant at the time this question-
naire was taken. Approximately 13% of women responded
that they had the desire to become pregnant within 24 months,
and 22% responded that they respected the recommended de-
lay of 24 months with their desire to become pregnant as is
shown in Table 5.
The odds ratio of receiving contraceptive counseling for
using safe contraceptive methods compared with no counsel-
ing was 2.20 (95% CI, 1.27–3.79; p = 0.005). Women who
received contraceptive counseling are more likely to use safe
contraceptives. There were no relevant confounders found
(age, civil status, education level, obesity clinic, and surgical
procedure were checked as possible confounders).
In the overall population, 71 women confirmed to have
received contraceptive counseling from one healthcare pro-
vider in the bariatric care program, and in this group, 63%
used safe contraception postoperatively.
Eleven women confirmed to have received contraceptive
counseling from 4 different healthcare providers, and 73% of
women in this group used a safe method of contraception
postoperatively. Despite this difference, we found no statisti-
cal significant relation found between receiving contraceptive
counseling from more than one healthcare provider and the
use of safe contraception postoperatively.
Discussion
This study in two obesity clinics in The Netherlands shows
that 60% of women who underwent bariatric surgery are
using a safe method of contraception postoperatively ac-
cording to international guidelines. About 24% of women
who underwent bariatric surgery responded not to use any
method of contraception postoperatively. As the question-
naire did not include questions regarding the status of sex-
ual activity, we could not distinguish the actual need for
contraception in this population. However, it is to be noted
that in this group of women, 89% reported to be involved
in a relationship, though we have no information whether
these relationships were heterosexual relationships and
sexual active relationships.
Approximately 63% of women could confirm to have re-
ceived counseling or information about contraception after
bariatric surgery. These results suggest that the quality of
counseling and prescribing of contraception in women who
undergo bariatric surgery needs improvements.
In this study, we observed a decrease in use of oral contra-
ceptives postoperatively; however, still 16.1% of women con-
tinued in using this unsafe method of contraception, according
to international guidelines. Further pharmacokinetic studies
Table 2 Overview of contraceptive use classified as safe, unsafe, and no use of contraception pre- and postoperatively (N = 230)
Postoperative
Safe contraception Unsafe contraception No contraception Total
Preoperative Safe contraception N 103 0 0 103
% 100.0% 0.0% 0.0% 100.0%
Unsafe contraception N 31 36 4 71
% 43.7% 50.7% 5.6% 100.0%
No contraception N 4 1 51 56
% 7.1% 1.8% 91.1% 100.0%
Total N 138 37 55 230
% 60.0% 16.1% 23.9% 100.0%
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investigating whether bariatric surgery affects the pharmaco-
kinetics of oral contraceptives are required to set this in more
perspective.
Our results regarding the use of contraception are in line
with the Swedish study done by Ginstman et al. (N = 563) in
which 15.5% were using oral contraceptives postoperatively
and 29.9% did not use any method of contraception [19]. In
the study from the USA by Mengesha et al. (N = 363), these
percentages were higher, respectively 27% oral contraceptives
and 34% no contraception postoperatively [18].
We also found that adequate contraceptive counseling
in the bariatric care program is important as this signif-
icantly improves the use of safe contraception postoper-
atively. However, we cannot exclude any influence of
other contributing factors which were not investigated
in this study.
As only 62.6% in our study could confirm to have received
contraceptive counseling and only 52.6% could indicate the
recommended pregnancy delay of 24 months postoperative, it
is worth thinking about how to improve this.
Table 3 Overview of survey
responses for receiving pre- and
postoperative counseling in con-
traception and/or pregnancy (N =
230)
Received counseling Contraceptive information Pregnancy information
N (%) N (%)
Yes 144 (62.6) 192 (83.5)
No 86 (37.4) 38 (16.5)
If yes, when and by which healthcare provider counseling was givena:
Preoperative by:
Surgeon 50 (34.7) 78 (40.6)
Internist 22 (15.3) 33 (17.2)
Nurse specialist obesity 58 (40.3) 88 (45.8)
Outpatient obesity nurse 72 (50.0) 105 (54.7)
General practitioner 12 (8.3) 17 (8.9)
Postoperative by:
Surgeon 5 (3.5) 8 (4.2)
Internist 2 (1.4) 5 (2.6)
Nurse specialist obesity 14 (9.7) 24 (12.5)
Outpatient obesity nurse 22 (15.3) 28 (14.6)
General practitioner 3 (2.1) 3 (1.6)
Other healthcare providers 6 (4.2) 10 (5.2)
Information sources:
Information meeting 102 (70.8) 139 (72.4)
Information map 47 (32.6) 67 (34.9)
Internet 43 (29.9) 43 (22.4)
Conversation 51 (35.4) 104 (54.2)
Group meeting 50 (34.7) 57 (29.7)
Other 1 (0.7) 1 (0.5)
a Participants could select > 1 choice
Table 4 Overview of survey responses for delaying pregnancy (N =
230)
Advised delay for pregnancy N (%)
12 months 50 (21.7%)
18 months 15 (6.5%)




Table 5 Overview of survey responses regarding the desire to become
pregnant (N = 230)
Desire to become pregnant N (%)
No 149 (64.8%)
Yes, but not within 24 months 50 (21.7%)
Yes, within 24 months 27 (11.7%)
Yes, within 12 months 4 (1.7%)
Now pregnant 0 (0.0%)
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It is notable that in our study, counseling was predominant-
ly recalled as given preoperatively and by the obesity nurse
and nurse specialist in the bariatric care program. Perhaps
postoperatively counseling is more effective as this is the set-
ting when it is most relevant and at this point after the opera-
tion, women may be more inclined to follow up on this.
Counseling by more than one healthcare provider may de-
crease the risk of using unsafe contraception postoperatively;
however, this was not statistically significant.
It may also be worthwhile to include general practitioners
and pharmacists in the outpatient setting in monitoring wheth-
er women who underwent bariatric surgery are using safe
contraception as they usually prescribe and dispense this con-
traception. For this reason, it is important that obesity clinics
actively inform these healthcare providers about the bariatric
surgery after discharge from the hospital. Furthermore, bariat-
ric surgery should be registered as a condition in the electronic
medical record of all healthcare providers for these women
with adequate signaling when contraindicated drugs, like oral
contraception, are prescribed or dispensed.
Strengths and Limitations
The results of this questionnaire study regarding contraceptive
and pregnancy counseling by whom and when, may have
been affected by recollection bias as the time between partic-
ipating in this study and the moment of counseling may have
been too long for some women for remembering this always
correctly. This study was also limited as we did not include
questions in the questionnaire regarding the status of sexual
activity as this may be a reason for not using contraception.
Final conclusions for this group must therefore be drawn with
caution.
The high response rate is the strength of this study.
Therefore, the results represent a good reflection of this bar-
iatric surgery population in the two obesity clinics in
The Netherlands investigated. The differentiation by whom
and when counseling was given, is informative and
strengthens this study, which we have used to formulate spe-
cific recommendations for improvements in counseling re-
garding contraception after bariatric surgery.
Conclusions
In this questionnaire study, we found that a substantial part of
women who underwent bariatric surgery is using potential
unsafe or no contraception. In this way, they are not only at
risk for an unwanted and unplanned pregnancy, but because of
the weight loss in the early months after bariatric surgery also
at risk for a pregnancy with adverse effects and complications.
Contraceptive and pregnancy counseling is suboptimal, and
improvements are necessary as we have demonstrated that this
is correlated with the use of safe contraception postoperative-
ly. We suggest implementingmore counseling and monitoring
in the postoperative and in the outpatient setting. Adequate
signaling in the electronic medical information systems for
contraindicated drugs like oral contraception after bariatric
surgery could be helpful for better monitoring and guidance.
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